Latest News

MRC Clinical Trials Unit at UCL researchers and our collaborators will present the latest research from our HIV trials at CROI 2024.
NeoCHG found that whole-body application of chlorhexidine is safe for hospitalised, premature newborn babies, paving the way for larger clinical trials to test how well it prevents deaths.
A new study shows that better prostate cancer treatments could reach men almost two years sooner than is currently possible.
Long-term follow-up results from the PIVOT trial confirm that protease inhibitor monotherapy preserves future drug options as well as standard combination therapy.
For our 25th anniversary celebrations, we explore the PRACTical trial design, which allows researchers to compare multiple treatments for diseases that don’t have a single “standard-of-care” treatment.